Cost-Effectiveness Analysis for Hepatitis C Treatment
Are direct-acting antivirals for the treatment of hepatitis C virus (HCV) more effective than peginterferon alfa and ribavirin (PEG/riba)? Researchers employed a generalized cost-effectiveness analysis…
Hepatitis C Evolution: From IFN Treatments to DAAs and Future Vaccine Research
This comprehensive overview of hepatitis C virus (HCV) infection includes its treatment history, genetic factors, resistance issues, and future research...